Loading clinical trials...
Loading clinical trials...
Observational Study Assessing the Biosimilar of Ustekinumab in Active Mucocutaneous Behçet's Syndrome Refractory or Intolerant to Conventional Approaches
Conditions
Locations
11
France
CHU BORDEAUX Hôpital Saint-André - Service de médecine interne
Bordeaux, France
Service de médecine interne-APHP - Henri Mondor
Créteil, France
HOPITAL CROIX-ROUSSE - HCL - service de médecine interne
Lyon, France
Hospices civils de Lyon
Lyon, France
GHSIF Melun
Melun, France
AP-HP-Hôpital COCHIN
Paris, France
Start Date
September 1, 2025
Primary Completion Date
April 30, 2026
Completion Date
December 31, 2029
Last Updated
November 24, 2025
Lead Sponsor
Groupe français d'étude des Maladies Inflammatoires de loeil
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions